Quick Answer
Apimeds Pharmaceuticals US, Inc. reported Total Assets of $13.1 thousand for the year ending 2024.
- Apimeds Pharmaceuticals US, Inc. showed a decrease of -96.9% in Total Assets from 2023 to 2024.
- This data is from Apimeds Pharmaceuticals US, Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2023 to 2024 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2024: $13.1 thousand | Q1 2025: $259.9 thousand | Q2 2025: $10.55 million | Q3 2025: $9.25 million.
- Historical annual values: Fiscal year 2024: $13.1 thousand | Fiscal year 2023: $422.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: